Muscarinic acetylcholine receptors (M 1 -M 5 ) regulate many key functions in the central and peripheral nervous system. Due to the lack of receptor subtype-selective ligands, however, the physiological roles of individual muscarinic receptor subtypes remain to be determined. In this study, we examined the effects of the muscarinic M 2 /M 4 receptor-preferring agonist [5R-(exo)]-6-[4-butylthio-1,2,5-thiadiazol-3-yl]-1-azabicyclo-[3.2.1]-octane (BuTAC) on serum corticosterone levels in M 2 and M 4 receptor single knockout (KO) and M 2,4 receptor double KO mice. Responses were compared with those obtained with the corresponding wild-type (WT) mice. BuTAC (0.03-0.3 mg/kg s.c.) dose dependently and significantly increased serum corticosterone concentrations in WT mice to 5-fold or greater levels compared with vehicle controls. In muscarinic M 2 and M 2,4 KO mice, however, BuTAC had no significant effect on corticosterone concentrations at doses of 0.1, 0.3, and 1 mg/kg s.c. In both WT and muscarinic M 4 KO mice increases in serum corticosterone concentrations induced by BuTAC (0.1 and 0.3 mg/kg) were not significantly different and were blocked by scopolamine. In summary, the muscarinic M 2,4 -preferring agonist BuTAC had no effect on corticosterone levels in mice lacking functional muscarinic M 2 receptors. These data suggest that the muscarinic M 2 receptor subtype mediates muscarinic agonist-induced activation of the hypothalamic-pituitary-adrenocortical axis in mice.There are five muscarinic acetylcholine receptor subtypes, designated M 1 , M 2 , M 3 , M 4 , and M 5 , widely expressed in the central nervous system and in the periphery. Muscarinic receptors modulate the activity of many neurotransmitter systems in the brain, play a key role in memory and learning, and regulate a great number of sensory, motor, and autonomic processes. Moreover, central cholinergic receptor dysfunction has been suggested to be involved in the pathophysiology of schizophrenia (Haroutunian et al